Skip to main content
COO logo

The Cooper Companies, Inc.

COONASDAQHealthcareMedical Instruments & Supplies

$61.65Today:- (-)1Y −17.27%

As of Oct 22, 2026 close

Market cap
$11.92B
P/E (TTM)
20.91
Forward P/E
15.13
Dividend yield
-
52-week range
$51.01$89.83
Volume (live)
-
Avg. volume (3M)
4.30M

The Cooper Companies (COO) Stock Price & Financial Analysis

The Cooper Companies Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$59.27 - $61.66
52-Week High$89.83
52-Week Low$51.01
Open$59.39
Volume (last close)3.51M
Average Volume (3M)4.30M
Earnings & Profitability
Revenue (TTM)4.24B
Net Income (TTM)570.30M
Free Cash Flow (TTM)678.00M
EPS (TTM)$2.91
Profit Margin13.46%
Operating Margin12.84%
Return on Equity (ROE)6.85%
Debt to Equity0.31
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateJul 26, 2023
Size & Valuation
Market Cap11.92B
Shares Outstanding193.40M
P/E Ratio (TTM)20.91
Forward P/E15.13
Price to Sales (P/S)2.81
Price to Book (P/B)1.43
EV/EBITDA15.32
Technical Indicators
50-Day MA$62.88
200-Day MA$69.81
1-Year Change−17.27%

Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology

Compare COO with other stocks

The Cooper Companies at a Glance

As of the Oct 22, 2026 close, The Cooper Companies (COO) has a market capitalization of $11.92B. The stock trades at 20.9× trailing earnings, 15.1× forward earnings and 2.8× sales. Over the trailing twelve months it earned $570.30M on revenue of $4.24B (a 13.5% profit margin) and generated $678.00M of free cash flow. Revenue grew 4.7% year over year.

As of its latest reported balance sheet, it holds $154.70M in cash and securities against $2.54B of debt, a net debt position of $2.39B.

The Cooper Companies does not currently pay a dividend.

The share price is down 17.3% over the past year. At $61.65 (the Oct 22, 2026 close) it sits within its 52-week range of $51.01 to $89.83, below its 200-day moving average of $69.81.

Based on 16 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $64.83, 5.2% above the Oct 22, 2026 close.

Frequently Asked Questions About The Cooper Companies

What is the current stock price for COO?

As of the Oct 22, 2026 close, COO stock trades at $61.65. The 52-week range is $51.01–$89.83, with a day range of $59.27–$61.66.

What is the P/E ratio for COO?

As of the Oct 22, 2026 close, The Cooper Companies's trailing twelve-month (TTM) P/E ratio is 20.9, meaning investors pay $20.9 for every $1 of annual earnings. The forward P/E is 15.1, reflecting analyst expectations for future earnings. The Cooper Companies operates in the Healthcare sector.

Does COO pay dividends?

The Cooper Companies does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.

What do analysts recommend for COO?

Based on ratings from 16 professional analysts over the last 90 days, the consensus for COO is Hold. The average 12-month price target is $64.83, a 5.2% upside from the Oct 22, 2026 close of $61.65.

What is the market cap of COO?

As of the Oct 22, 2026 close, The Cooper Companies's market capitalization is $11.92B, classifying it as a large-cap company. The Cooper Companies operates in the Healthcare sector within the Medical Instruments & Supplies industry.